Racial/Ethnic and Socioeconomic Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus in an Insured Population

BACKGROUND: The high cost of direct-acting antiviral agents (DAAs) for hepatitis C virus (HCV) infection may present a barrier to access, thus contributing to disparities in treatment. However, few real-world data exist on factors associated with DAA uptake. METHODS: We conducted an observational st...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcus, Julia, Hurley, Leo, Chamberland, Scott, Champsi, Jamila, Gittleman, Laura, Korn, Daniel, Lai, Jennifer, Quesenberry, Charles, Ready, Joanna, Saxena, Varun, Seo, Suk, Witt, David, Silverberg, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631605/
http://dx.doi.org/10.1093/ofid/ofx163.380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5631605/
http://dx.doi.org/10.1093/ofid/ofx163.380

Ejemplares similares